| Bioactivity | P552-02 (552-02) mesylate is a sodium channel blocker that is potentially used for the treatment of cystic fibrosis, exhibiting biological activity that enhances mucociliary clearance in the lungs while minimizing the risk of hyperkalaemia. |
| CAS | 587879-54-7 |
| Formula | C20H30ClN7O7S |
| Molar Mass | 548.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia |
P552-02 mesylate
CAS: 587879-54-7 F: C20H30ClN7O7S W: 548.01
P552-02 (552-02) mesylate is a sodium channel blocker that is potentially used for the treatment of cystic fibrosis, exh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.